Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute — Boston, Massachusetts

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute is a clinical research site located in Boston, Massachusetts, United States 02115.

Crixeo Health Trust Score: 90/100 (GOOD). This profile has not yet been claimed by the site owner.

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute has participated in 159 clinical trials.

Therapeutic areas: Sarcoma, Leukemia, Myelodysplastic Syndromes.

Sponsors: Alliance for Clinical Trials in Oncology, Children's Oncology Group, Pediatric Brain Tumor Consortium.

Sponsor Feasibility Report

Trust Score: 90/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute?

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute has a Crixeo Trust Score of 90/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute conducted?

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute has 159 clinical trials on record. Their work covers Sarcoma, Leukemia, Myelodysplastic Syndromes.

Is Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute accredited by Crixeo Health?

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.